A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease by Braga, Felipe Vieira et al.
  
 University of Groningen
A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in
health and disease
Braga, Felipe Vieira; Kar, Gozde; Berg, Marijn; Carpaij, Orestes; polanski, krystof; Simon,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Braga, F. V., Kar, G., Berg, M., Carpaij, O., polanski, K., Simon, L., ... Teichmann, S. A. (2019). A cellular
census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease.
Manuscript submitted for publication. https://doi.org/10.1101/527408
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




A cellular census of healthy lung and asthmatic airway wall identifies novel cell states 2 
in health and disease 3 
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Human lungs enable efficient gas exchange, and form an interface with the environment 53 
which depends on mucosal immunity for protection against infectious agents. Tightly 54 
controlled interactions between structural and immune cells are required to maintain lung 55 
homeostasis. Here, we use single cell transcriptomics to chart the cellular landscape of 56 
upper and lower airways and lung parenchyma in health. We report location-dependent 57 
airway epithelial cell states, and a novel subset of tissue-resident memory T cells. In lower 58 
airways of asthma patients, mucous cell hyperplasia is shown to stem from a novel mucous 59 
ciliated cell state, as well as goblet cell hyperplasia. We report presence of pathogenic 60 
effector Th2 cells in asthma, and find evidence for type-2 cytokines in maintaining the altered 61 
epithelial cell states. Unbiased analysis of cell-cell interactions identify a shift from airway 62 
structural cell communication in health to a Th2-dominated interactome in asthma. 63 
 64 
 65 
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The lung plays a critical role in both gas exchange and mucosal immunity, and its anatomy 68 
serves these functions through (1) the airways that lead air to the respiratory unit, provide 69 
mucociliary clearance, and form a barrier against inhaled particles and pathogens; and (2) 70 
the alveoli, distal saccular structures where gas exchange occurs. Acute and chronic 71 
disorders of the lung are a major cause of morbidity and mortality worldwide1. To better 72 
understand pathogenesis of lung disease, it is imperative to characterise the cell types of 73 
the lung and understand their interactions in health2,3 and disease. The recent identification 74 
of the ionocyte as a novel airway epithelial cell-type4,5 underscores our incomplete 75 
understanding of the cellular landscape of the lung, which limits our insight into the 76 
mechanisms of respiratory disease, and hence our ability to design therapies for most lung 77 
disorders.  78 
 79 
We set out to profile lung-resident structural and inflammatory cells and their interactions by 80 
analysing healthy human respiratory tissue from four sources: nasal brushes, endobronchial 81 
biopsies and brushes from living donors, and tissue samples from lung resections and 82 
transplant donor lungs. Our single cell analysis identifies differences in the proportions and 83 
transcriptional phenotype of structural and inflammatory cells between upper and lower 84 
airways and lung parenchyma. Using an unbiased approach to identify tissue-resident CD4 85 
T cells in airway wall, we identify a novel tissue migratory CD4 T cell (TMC) that harbours 86 
features of both circulating memory cells and of tissue resident memory cells (TRM) CD4 T 87 
cells. We demonstrate that many disease-associated genes have highly cell type-specific 88 
expression patterns. This holds true for both rare disease-associated genes, such as CFTR 89 
mutated in cystic fibrosis, as well as genes associated with a common disease such as 90 
asthma.  91 
 92 
In addition, we evaluate the altered cellular landscape of the airway wall in chronic 93 
inflammatory disease using bronchial biopsies from asthma patients. We identify a novel 94 
epithelial cell state highly enriched in asthma, the mucous ciliated cell. Mucous ciliated cells 95 
represent a transitioning state of ciliated cells with molecular features of mucus production, 96 
and contribute to mucous cell hyperplasia in this chronic disease. Other changes associated 97 
with asthma include increased numbers of goblet cells, intraepithelial mast cells and 98 
pathogenic effector Th2 cells in airway wall tissue. We examine intercellular communications 99 
occurring in the healthy and asthmatic airway wall, and reveal a remarkable loss of epithelial 100 
communication and a concomitant increase in Th2 cell interactions. The newly identified 101 
TMC subset interacts with epithelial cells, fibroblasts and airway smooth muscle cells in 102 
asthma. Collectively, these data generate novel insights into epithelial cell changes and 103 
altered communication patterns between immune and structural cells of the airways, that 104 
underlie asthmatic airway inflammation. 105 
A human lung cell census identifies macro-anatomical patterns of epithelial cell 106 
states across the human the respiratory tree 107 
The cellular landscape along the 23 generations of the airways in human lung is expected 108 
to differ both in terms of relative frequencies of cell types and their molecular phenotype6. 109 
We used 10x Genomics Chromium droplet single-cell RNA sequencing (scRNA-Seq) to 110 
profile a total of 36,931 single cells from upper and lower airways, and lung parenchyma 111 
(Figure 1A, B). We profiled nasal brushes, and (bronchoscopic) brushes and biopsies from 112 
airway wall (third to sixth generation) from healthy volunteers. For parenchyma (small 113 
respiratory airways and alveoli), we obtained lung tissue from deceased transplant donors, 114 
also analysed on the 10x platform, and from non-tumour resection tissue from lung cancer 115 
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patients, analysed on a bespoke droplet microfluidics platform based on the Dropseq 116 
protocol 7.  117 
 118 
Integration of the data from nasal epithelium, airway wall and parenchymal tissue reveals a 119 
diversity of epithelial, endothelial, stromal and immune cells, with approximately 21 coarse-120 
grained cell types in total (Figures 1 and 2, Extended Figure 1), that can be explored in user-121 
friendly web portal (www.lungcellatlas.org).  Analysis of parenchymal lung tissue from 122 
resection material using Dropseq led to the identification of 15 coarse-grained cell 123 
populations (epithelial and non-epithelial) (Extended Figure 2). Using MatchSCore8 to 124 
quantify the overlap between cell type marker signatures between the two datasets revealed 125 
an extensive degree of overlap in cell type identities (Extended Figure 2). In our analysis 126 
below, we first concentrate on epithelial cells (Figure 1), and then focus on the stromal and 127 
immune compartments (Figure 2). 128 
 129 
In the epithelial lineage, we identified a total of at least 10 cell types across the upper and 130 
lower airways and lung parenchyma (Figure 1C, Extended Data Figure 1). We detected 131 
multiple basal, club, ciliated and goblet cell states, as well as type-1 (T1) and type-2 (T2) 132 
alveolar cells, and the recently described ionocyte4,5 (Extended Figure 3). Both goblet and 133 
ciliated cells were present in the nasal epithelium (Figure 1D). In the lower airways, we 134 
detected basal, club and ciliated cells as well as ionocytes, but only very small numbers of 135 
goblet cells. T1 and T2 cells were, as expected, only found in the lung parenchyma (Figure 136 
1E).  137 
 138 
We did not identify specific clusters of tuft cells or neuroendocrine (NE) cells. Since cell 139 
types represented by a small fraction of the data might be missed by unsupervised 140 
clustering, we evaluated the expression of known marker genes for NE cells (CHGA, 141 
ASCL1, INSM1, HOXB5) and Tuft cells (DCLK1, ASCL2)4. NE marker genes identified a 142 
small number of cells, present only in lower airways, displaying a transcriptional profile 143 
consistent with that of NE cells (extended Figure 4). Tuft cell marker genes did not identify 144 
a unique cell population. Ionocytes were found in lower airways, and at very low frequency 145 
in upper airways, but were completely absent from the parenchyma. Comparison of the cell 146 
populations identified using the two different bronchoscopic sampling methods (brush 147 
versus biopsy) in lower airways showed that basal cells were captured most effectively in 148 
biopsies, while apical epithelial cells, such as ciliated and club cells were relatively 149 
overrepresented in the bronchial brushings (Figure 1D).  150 
 151 
Our dataset allowed us to identify two discrete cell states in basal, goblet and ciliated 152 
epithelial cells. Some of these cell phenotypes were restricted to specific anatomical 153 
locations along the respiratory tract. Basal cells were present in both upper and lower 154 
airways, although at relatively low frequency in upper airways (Figure 1E). The two basal 155 
cell states corresponded to differentiation stages, with the less mature Basal 1 cell state 156 
expressing higher levels of TP63 and NPPC in comparison to Basal 2 cells (Figure 1F and 157 
extended data 1), which were more abundant in bronchial brushes, suggesting a more apical 158 
localization for these more differentiated basal cells (Figure 1D). Goblet 1 and 2 cells were 159 
both characterized by high expression of CEACAM5, S100A4, MUC5AC and lack of MUC5B 160 
(Figure 1F and Extended Figures 1 and 4). Goblet 1 cells specifically express KRT4 and 161 
CD36 (Figure 1G and Extended Figure 4). Genes involved with immune function, such as 162 
IDO1, NOS2, IL19, CSF3 (Granulocyte-colony stimulating factor) and CXCL10 are 163 
expressed at high levels in Goblet 2 cells (Figure 1G and Extended Figure 4). These 164 
molecules enriched in Goblet 2 cells are involved in recruitment of neutrophils, monocytes, 165 
dendritic cells and T cells9. Both goblet cells states are present in upper airway epithelium, 166 
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with Goblet 1 cells being more frequent. In contrast, the Goblet 2 cell state was also present 167 
in lower airways, albeit at low abundance (Figure 1E).  168 
 169 
Ciliated cell transcriptional phenotypes are also zonated in terms of their presence across 170 
macro-anatomical locations, with a discrete ciliated cell state more abundant in upper 171 
airways (Ciliated 2) compared to lower airways and parenchyma. Nasal epithelial Ciliated 2 172 
cells express pro-inflammatory genes, such as CCL20 (Extended data 3) and higher levels 173 
of metabolic genes (ATP12A and COX7A1) and vesicle transport (AP2B1 and  SYT510) 174 
compared to the Ciliated 1 cell state. In contrast, the Ciliated 1 cells from lower airways 175 
specifically expressed genes involved in cytoprotection (PROS111) and fluid reabsorption 176 
(FXYD112) (Figure 1H and Extended Figure 4). Interestingly, comparison of the location-177 
specific differences between ciliated and goblet cells identified a transcriptional signature 178 
specific for the upper airways present in both epithelial cell types (Extended Figure 4B). 179 
 180 
Next, we assessed the contribution of specific epithelial cell types to Mendelian disease. 181 
Cell-type specific expression patterns of genes associated with Mendelian disorders (based 182 
on the Online Mendelian Inheritance in Man, OMIM database) confirm ionocytes as 183 
particularly high expressers of the CFTR gene, mutated in cystic fibrosis (Figure 1I). These 184 
cells also express SCNN1B, mutations of which can cause bronchiectasis, another feature 185 
of cystic fibrosis, suggesting a potential key pathological role for ionocytes in both 186 
bronchiectasis and cystic fibrosis. In addition, expression of SERPINA1 (Figure 1I) was 187 
found to be enriched in type-2 alveolar epithelial cells, underscoring their role in alpha-1-188 
antitrypsin deficiency13. 189 
Differential anatomical distribution of the stromal and immune components in the 190 
human respiratory tree 191 
Next, we analysed the single cell transcriptomes of immune and stromal cells from the upper 192 
airways, lower airways and the lung parenchyma (Figure 2A). We identified immune clusters 193 
of myeloid (macrophages, neutrophils, dendritic cells (DCs) and mast cells) and lymphoid 194 
cells (T and NK cells, B cells; Figure 2B, and Extended Figure 5). Immune and stromal cell 195 
numbers and composition varied greatly across different anatomical regions (Figure 2A and 196 
2C). Nasal brushes contained only a small number of immune cells, with the large majority 197 
being dendritic cells. In the lower airways, the fraction of inflammatory cells was significantly 198 
larger and relatively enriched for macrophages (Figure 2C and Extended Figure 5), which 199 
was directly confirmed by cell composition comparison of upper versus lower airway brushes 200 
obtained from the same donor (Extended Figure 5E).  201 
 202 
Macrophages show large donor variation in their phenotype (Extended figure 5), but they all 203 
share high expression of MARCO, CCL18 and genes involved in apolipoprotein metabolism 204 
(APOC1 and APOE) (Figure 2E). Lung neutrophils express high levels of the granulocyte 205 
markers S100A8, S100A1214 and LILRA5, a receptor poorly characterised in the lungs, that 206 
has been shown to have a proinflammatory function in synovial fluid macrophages 15 (Figure 207 
2E). DCs were mostly myeloid, with high expression of CD1E, CD1C, CLEC10A (Figure 2E) 208 
and of FCER1A (IgE receptor) and CCL17, molecules known to play a key role in 209 
inflammatory conditions such as asthma16.  210 
 211 
In the droplet RNAseq data sets, we could not distinguish CD4+ and CD8+ T cells and NK 212 
cells from each other (Figure 2B). The B cells in our dataset were mostly plasma cells, 213 
expressing high levels of JCHAIN (Joining Chain of Multimeric IgA And IgM). IgM+ (IGHM) 214 
cells were enriched in the airway lumen and in the lung parenchyma, while IgG3+ (IGHG3) 215 
were enriched in airway biopsy samples and were virtually absent from the airway lumen. 216 
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This suggests an isotype-driven micro-anatomical segregation of B cells in the airways 217 
(Extended Figure 5F). 218 
Molecular features of mucous cell metaplasia in asthma 219 
To characterize the changes in the cellular landscape of airway wall in a chronic 220 
inflammatory condition, we also analysed bronchial biopsies from six volunteers with 221 
persistent, childhood-onset asthma (Figure 3A). Asthma is a complex disease17 and multiple 222 
cells such as epithelial18,19, endothelial20 and immune cells21,22 have been shown to be 223 
altered in asthma. The combined airway wall dataset reveals a cellular landscape dominated 224 
by epithelial (EPCAM-positive) cells, with minor contributions from endothelial, 225 
mesenchymal and immune cells (Extended Figure 6A and B).  226 
 227 
High-resolution clustering of the EPCAM+ clusters identifies 10 sub clusters representing the 228 
6 epithelial cell types observed in healthy airway wall (Figure 1C), as well as two additional 229 
basal cell states: a mucous ciliated cell state, and serous cells from the submucosal glands 230 
(Figure 3B). In addition to the two basal cell states observed in healthy airway wall (Figure 231 
1C), the basal cell states in asthma include activated and cycling cell states (Figure 3B). 232 
Activated basal cells closely resemble Basal 1 cells in their transcriptional phenotype, but 233 
also express proinflammatory genes such as POSTN (Figure 3D). Cycling basal cells are 234 
characterized by expression of canonical marker genes of proliferating cells (MKI67 and 235 
TOP2A) (Figure 3D), and this is the only cluster of airway epithelial cells expressing the 236 
squamous cell marker KRT13 (Extended Figure 6).  237 
 238 
We observe mucous cell hyperplasia in asthma, with a strong increase in goblet cell 239 
numbers (Figure 3C), which are very rare in healthy airway wall biopsies (Figure 1E). 240 
Moreover, the goblet cell transcriptional phenotype is altered in asthma, with strongly 241 
increased expression of MUC5AC and SPDEF, as well as proinflammatory and remodelling 242 
genes including NOS2, CEACAM5 and CST1 (Figure 3D). In addition, we identify a strong 243 
increase in mucous ciliated cells, a novel cell state that has remarkable transcriptional 244 
resemblance to ciliated cells, whilst co-expressing a number of mucous genes, including 245 
MUC5AC, SERPINB2/3 and CEACAM5 (Figure 3D, Extended Figure 6). Mucous ciliated 246 
cells lack expression of the transcription factor SPDEF (in contrast to club and goblet cells), 247 
while maintaining FOXJ1 expression, underscoring their ciliated cell origin (Extended Figure 248 
7).  249 
 250 
To further dissect the inferred differentiation trajectories in healthy and asthmatic airway wall 251 
epithelial cells, we performed pseudotime analysis23. This reveals a trajectory starting with 252 
basal cell subsets, bifurcating into either a secretory lineage (mainly club cells) or a ciliated 253 
lineage in healthy airway wall (Figure 3E). In asthma, the secretory lineage is a mix of club 254 
and goblet cells, while the mucous ciliated cell state overlaps with the ciliated differentiation 255 
trajectory (Figure 3E,F). 256 
 257 
Next, we further analysed the transcriptional profiles of the two mucous cell states we 258 
observe specifically in asthma: the mucous ciliated cells and the goblet cells. As both 259 
NOTCH and IL4/IL13 signalling have been shown to contribute to mucous cell 260 
differentiation24, we analysed expression of both NOTCH target genes25,26 and IL4/IL13 261 
target genes27 in club, goblet, and ciliated cells as well as in the novel mucous ciliated cell 262 
state, in both asthma and healthy airway wall biopsies. Expression of IL4/IL13-induced 263 
genes27 is prominent in asthma, and highest in activated basal cells, goblet cells and mucous 264 
ciliated cells (Extended Figure 7). In club cells, expression of NOTCH target genes25,26 is 265 
not different between asthma and healthy-derived cells. In contrast, in goblet cells, the 266 
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NOTCH target gene signature is retained only in cells from healthy airway wall, and is lost 267 
in asthma.  268 
 269 
As in goblet cells, mucous ciliated cells also lack expression of Notch target genes in asthma 270 
(Extended Figure 7). Hence, we postulate that mucous ciliated cells represent a transition 271 
cell state in the ciliated lineage - induced by IL4/IL13 signalling - leading to a mucous cell 272 
phenotype which contributes to mucous cell metaplasia in asthma24. Similar to goblet cells, 273 
mucous ciliated cells express asthma genes such as CST128 and POSTN (Figure 3D), 274 
indicating that these cells also contribute to airway inflammation and remodelling. 275 
 276 
Integrating the asthma GWAS genes with our epithelial single cell transcriptomic data 277 
reveals a broad contribution of the airway epithelial cell types to asthma susceptibility (Figure 278 
3G), with high expression of  asthma GWAS genes in ciliated and mucous ciliated cells. This 279 
includes genes involved in cilia function (DYNC2H1 and KIF3A), cell adhesion (ELK3, 280 
CDHR3 and PTPRT) and IL5-induced mucus metaplasia (IL5RA)29, further suggesting a 281 
direct link between mucous ciliated cells and Th2 CD4 T cells.   282 
 283 
Remodelling of the stromal and Immune compartments in asthmatic airways 284 
Asthma is associated with chronic inflammation and remodelling of the airway wall30. 285 
Analysis of the inflammatory and stromal cell populations in the bronchial biopsies by 286 
unsupervised clustering (Figure 4A) reveals the presence of B and T cells, neutrophils, 287 
macrophages, DCs, mast cells, fibroblasts, smooth muscle cells and endothelial cells 288 
(Figure 4B, Extended Figure 8). We did not detect any innate lymphoid cells, basophils or 289 
eosinophils as separate clusters (Extended Figure 8). Analysis of bulk transcriptome 290 
analysis of whole airway biopsies before and after tissue dissociation identified very low 291 
expression levels of eosinophil marker genes (CLC and IL5RA), indicating these cells are 292 
relatively rare in the samples we analysed (Extended Figure 9). 293 
 294 
Mast cell numbers were increased in asthma (Figure 4C), while being virtually absent in the 295 
airways of healthy individuals (Figure 4C). Mast cells in asthmatic airways lack chymase 1 296 
expression (CMA1) and express high levels of tryptase genes (TPSB2, TPSAB1) (Figure 297 
4D). Prostaglandins and leukotrienes are known to be crucial to inflammatory cell signalling. 298 
Mast cells express high levels of PTGS2 and HPGDS (Figure 4D, Extended Figure 10). 299 
PTGS2 (cyclooxygenase-2), also known as inflammatory cyclooxygenase, converts the 300 
precursor arachidonic acid to prostaglandin endoperoxide H2 (PGH2). HPGDS 301 
(Hematopoietic Prostaglandin D Synthase) catalyses the conversion of PGH2 to 302 
prostaglandin D2 (PGD2). PGD2 activates CD4 Th2 cells31, ILC232, basophils and 303 
neutrophils31 and plays a key role in asthma pathology. Expression of all PGD2 biosynthesis 304 
enzymes is a unique feature of mast cells (Extended Figure 10) and this suggests that 305 
intraepithelial mast cells are continually producing PGD2 in asthma patients. Thus, these 306 
cells are most likely intraepithelial mast cells, previously shown to accumulate in Th2-high 307 
asthmatic airway epithelium33, and reported to be increased34 with disease severity21. 308 
 309 
We observed an increase in the number of B cells in the asthmatic airways ( Figure 4C) and 310 
these cells have a plasma cell phenotype, with high JCHAIN expression (Figure 4D). The 311 
increase in B cell numbers was mostly of IgM+ cells (IGHM) (Figure 4E). IgM levels in 312 
asthma BALF samples have been reported to be either increased34 or unchanged 35, 313 
suggesting cohort dependent variability. IgM-producing B cells in the healthy airways were 314 
mostly present in the airway lumen (Extended Figure 5F). However, as we did not analyse 315 
brush samples from asthmatic patients, we cannot precisely pinpoint whether the increase 316 
in IgM+ B cells takes place in the intraepithelial region or in the lumen, as both regions are 317 
present in biopsy samples. 318 
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Asthma GWAS genes show highly cell-type restricted expression (Figure 4F). When 320 
excluding the widely expressed HLA genes from the analysis, fibroblasts and T cells express 321 
the highest number of asthma GWAS genes (Figure 4F), which are mostly upregulated in 322 
asthma (Figure 4F). GATA3 expression is restricted to T cells (Figure 4F), and increased in 323 
T cells from asthma patients (Figure 4F and G). We detected increased expression of CD4 324 
(but not CD8a) in the T cell cluster, suggesting an increase in Th2 CD4 T cells (Figure 4G). 325 
Therefore, we next proceed to investigate the CD4 T cell compartment in depth. 326 
Pathogenic effector Th2 cells are enriched in asthmatic airways 327 
In line with the increase in GATA3 and CD4 expression mentioned above, CD4 Th2 cells 328 
are known to be key drivers of asthma17,36. To assess the presence of Th2 effector cells in 329 
the airways of asthma patients (Figure 4G), we single cell sorted CD4 T cells followed by 330 
plate-based SmartSeq2 analysis for in depth transcriptional phenotyping of the T helper cell 331 
compartment (see Methods for details). We analysed cells from both peripheral blood and 332 
airway wall biopsies (Figure 5A) from a larger cohort of asthma patients and healthy controls 333 
(Figure 5B). Unbiased clustering reveals six major populations of CD4 T cells (Figure 5C 334 
and Extended Figure 11). At this coarse level of analysis, none of these six clusters was 335 
specifically enriched in asthma patients (Figure 5D).  336 
 337 
Comparative analysis of CD4 T cells isolated from paired blood and lung samples allows us 338 
to differentiate between tissue-resident T cells and circulating T cells in an unbiased way, 339 
by subtracting the populations shared with blood from the populations specific to the 340 
biopsies (Figure 5E). Using this approach, we identified two subsets highly enriched in the 341 
lungs: the classical Tissue Resident Memory (TRM) CD4 T cells, and a novel subset we 342 
named Tissue Migratory CD4 T cell (TMC)  (Figure 5E). Naive/central memory (CM), effector 343 
memory (EM), and EMRA cells, as well as a mixed Treg/Th2 cluster, are either enriched in 344 
blood or present in both blood and airways (Figure 5E). 345 
  346 
To better understand the two distinct lung-restricted CD4 T cell subsets, we performed 347 
differential expression analysis between TRM and TMC cells (Figure 5F). Several 348 
transcription factors highly expressed in circulating cells are enriched in TMC cells, such as 349 
LEF1, SATB1 and KLF3, while ZEB2 is specific for TRM cells. TMC cells expressed the 350 
tissue egression markers S1PR1, CCR7 and SELL (CD62L) and lacked expression of the 351 
canonical TRM marker ITGAE (CD103) (Figure 5F). As low numbers of TMC cells were 352 
present in peripheral blood CD4 T cells (Figure 5E), these data suggest that these cells have 353 
the potential to transit between lung and blood, a hypothesis supported by pseudotime 354 
trajectory analysis of the CD4 T cell subsets (Extended Figure 12).  355 
 356 
Protein expression of CD69 and CD103 (ITGAE) have both been used as hallmarks of lung 357 
resident CD4 T cells isolated from lung parenchyma37,38, but to the best of our knowledge, 358 
no similar analysis of lung airway epithelial CD4 T cells has been performed to date. Both 359 
TMC and TRM cells have high expression of CD69, but only TRM cells express ITGAE 360 
(Extended Figure 11), suggesting these subsets might be equivalent to the previously 361 
described cells37,38 However, TRM cells37,38 have been shown to lack S1PR1 and CCR7 362 
protein expression, in contrast to TMC cells that express high mRNA levels of both markers. 363 
No direct whole transcriptome comparison of CD69+CD103+ versus CD69+CD103- TRMs 364 
has been performed  yet37,38. Further studies are necessary to properly compare CD4 T cells 365 
from airway wall versus lung parenchyma, and investigate how TMC align with the previously 366 
reported TRM subsets at the transcriptome level. 367 
 368 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/527408doi: bioRxiv preprint first posted online Jan. 23, 2019; 
9 
 
TRM cells in airway wall expressed high levels of CXCR6 and ITGA1 and high levels of 369 
cytokines (CCL4, CCL4L2, CCL5) and effector molecules (PRF1, GZMB, GZMA, GZMH) 370 
(Figure 5F and Extended Figure 11), indicating they are also in a primed state capable of 371 
direct effector function, as recently shown for TRMs from lung parenchyma37. 372 
 373 
CD4 effector T cells are classically divided into distinct functional subsets based on their 374 
cytokine profile17. We manually annotated clusters of Th1 (IFNG+), Th2 (IL4+, IL5+ or IL13+) 375 
and Th17 (IL17A+ or IL17F+) cells based on their cytokine expression profiles (Figure 5G, 376 
Extended Figure 13). Cytokine-producing cells were mostly retrieved from the biopsies, with 377 
only very few present in blood (Extended Figure 14).  378 
 379 
In terms of absolute numbers, Th2 cells were very rare and found both in healthy and 380 
asthmatic patients, although numbers of Th2 cells were significantly increased in the airway 381 
wall in the asthma patients, with no detected difference in the relative proportions of the 382 
other subsets (Figure 5H). In addition to the signature cytokines and the transcription factor 383 
GATA3 (Extended Figure 13), airway wall Th2 cells express HGPDS, identifying them as 384 
pathogenic effector Th2 (peTh2) cells, previously associated with eosinophilic inflammation 385 
of the gastrointestinal tract and skin39. Airway Th2 also express the transcription factor 386 
PPARG, and cytokine receptors IL17RB and IL1RL1 (Figure 5I). IL17RB and IL1RL1 have 387 
been reported as upregulated in pathogenic allergen-specific Th2 cells (coined Th2A cells), 388 
which are present in allergic disease40 as well as in chronic rhinosinusitis with nasal polyps41, 389 
suggesting airway wall Th2 cells share features with both Th2A and peTh2 cells. 390 
Asthma is characterized by specific signalling networks  391 
Asthma is characterized by remodelling of the airways, which depends on complex 392 
interactions between structural and inflammatory cells17, both via direct physical interactions 393 
and via secreted proteins and small molecules. We used our recently developed 394 
receptor/ligand database and statistical inference framework CellPhoneDB42 395 
(www.cellphonedb.org), to chart combinatorial cell-specific expression patterns of genes 396 
encoding receptor/ligand pairs. We aim to identify potential cell-cell interactions in the airway 397 
wall, and define their changes in asthma. Whilst most interactions are unchanged, some 398 
were specific to the diseased or healthy state (Full list in Extended 6).  399 
 400 
In healthy controls, the cell-cell interaction landscape of the airway wall was dominated by 401 
lung structural cells (mainly mesenchymal and epithelial cell types) communicating with 402 
other lung structural cells and with tissue-resident T cells, both the classical TRM and the 403 
newly identified TMC subsets (Figure 6A,B, left panels). In the asthmatic airway wall, the 404 
number of predicted interactions between epithelial and mesenchymal cells was strongly 405 
reduced. Instead, the cell-cell communication landscape in asthmatic airway wall is 406 
dominated by Th2 cells that were found to have increased interactions with other immune 407 
cells, including antigen-presenting cells, and also with epithelial cells ((Figure 6A,B, right 408 
panels). The most striking increase in interactions is with mesenchymal cells, both 409 
fibroblasts and smooth muscle cells (Figure 6A and B, right panels).  410 
 411 
Analysis of the predicted cell-cell interactions between structural cells in healthy airway wall 412 
revealed a wealth of growth factor-signalling pathways including the FGF, GFR, IGF, TGF, 413 
PDGF and VEGF pathways, most of which were lost in the asthmatic samples (Figure 6C). 414 
Detailed analysis of the individual interactions of Th2 cells with the inflammatory and lung 415 
structural cells unique to asthma revealed the potential of Th2 cells to have cognate 416 
interactions with the epithelial cells involving KLRG1 and CD103 binding to E-cadherin, and 417 
also integrin-mediated interactions with epithelial-expressed matrix proteins such as 418 
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Tenascin-C. Epithelial expression of alarmins and cytokines, such as IL33, TSLP (Figure 419 
3G) and TNFSF10/TRAIL (Figure 6D), all of which are asthma genes43–45, might then lead 420 
to activation of Th2 cells expressing the receptors.  421 
 422 
In addition to validating these well-known interactions, which for IL33 and TSLP failed to 423 
reach significance in our unbiased cell-cell interaction analysis, we identify novel epithelial-424 
Th2 cell interactions in asthma, including chemokines CXCL2 and CXCL17, and the cytokine  425 
MIF that are all expressed by epithelial cells, while Th2 cells express the respective 426 
receptors (Figure 6C). Interestingly, mesenchymal cells share some of these Th2 cell 427 
interactions, such as expression of TNFSF10/TRAIL and MIF. Predicted Th2 interactions 428 
unique to mesenchymal cells in asthmatic airway wall are CXCL12 and CCL11, expressed 429 
by fibroblasts and smooth muscle cells. Airway wall Th2 cells in asthma express the 430 
cytokines IL5 and IL13 (Figure 5I), the receptor complexes for which are expressed by 431 
immune cells and epithelial cells, respectively, in line with the expression of IL13-driven 432 
genes in mucous ciliated and goblet cells in asthma (Extended data Figure 7). In addition to 433 
these classical Th2 cytokines, Th2 cells express LTB for which basal epithelial cells express 434 
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Our study profiles the cellular landscape of human lung tissue at the single-cell level, 444 
including both upper and lower airways and parenchymal lung tissue in healthy adults. We 445 
identify at least 21 main cell types in the normal human lung, that can be further subdivided 446 
into more fine-grained cell states. There is clear Mendelian disease relevance for many cells, 447 
including the previously-reported ionocytes (for bronchiectasis and cystic fibrosis), and type-448 
2 alveolar cells (for alpha-1-antitrypsin deficiency) . We chart differences in frequencies and 449 
molecular state of airway epithelial cells between upper and lower airways. To our 450 
knowledge, we provide for the first time a detailed molecular description of tissue-resident 451 
CD4 T cells in the human lower airway wall, and identify two separate subsets, one of which 452 
was hitherto unknown.  453 
 454 
In our studies, we deployed two different droplet-based single-cell RNA sequencing 455 
platforms and one plate-based method, with experiments performed in three geographically 456 
distinct research centers. Overall, the datasets are remarkably consistent, which yields a 457 
quantitative dataset of the cellular composition of human upper and lower airways and lung 458 
parenchyma.  459 
 460 
In addition to analysing healthy reference samples, we characterize the changes in the cell 461 
types and cell states in airway wall in asthma. This reveals mucous ciliated cells as a novel 462 
cell state that contributes to mucous cell metaplasia. Both mucous ciliated and goblet cells 463 
are characterized by expression of an IL4/IL13-driven gene signature, indicating a dominant 464 
role for type-2 cytokines in maintaining the epithelial changes in chronic airway inflammation 465 
in asthma. The mucin gene expression induced in FOXJ1+ cells with an unabated ciliated 466 
cell transcriptional profile strongly indicates that the mucous state is superimposed on the 467 
ciliated cell phenotype, independent of goblet cell differentiation from club cells. Our data 468 
seem to indicate that these two processes can occur in parallel, with mucous metaplasia of 469 
ciliated cells and goblet cell hyperplasia both contributing to the increase in mucin-producing 470 
cells in asthma. Whether the mucous ciliated cells go on to lose their FOXJ1 expression and 471 
the ciliated transcriptional profile and transdifferentiate into bona fide SPDEF-positive goblet 472 
cells remains to be firmly established.  473 
 474 
The epithelial cell changes in airway wall in asthma are surprisingly different to those 475 
recently described in patients with in chronic rhinosinusitis with polyps27. In this chronic 476 
inflammatory disease of the upper airways caused by exaggerated type-2 immunity, an 477 
IL4/IL13-driven gene transcription profile was mainly observed in basal epithelial cells, which 478 
were found to be arrested in differentiation and highly increased in numbers27. Using the 479 
same IL4/IL13-driven gene module, we find some expression thereof in basal cells, but in 480 
asthma this does not result in significant changes in basal cell numbers. Instead, we observe 481 
an increased number of goblet cells, as well as of mucous ciliated cells, both of which show 482 
evidence of marked expression of the IL4/IL13-driven gene signature (extended data Figure 483 
7). Hence, while there is some overlap in the cellular mechanisms underlying rhinosinusitis 484 
with polyps and asthma, the resultant changes in cellular states and their frequencies in 485 
airway wall differ considerably between the epithelia of the upper versus the lower airways. 486 
In contrast, the changes in the eicosanoid pathway observed in chronic type-2 inflammation 487 
of the upper27 and lower (extended data Figure 10) airways are very similar, likely reflecting 488 
a common cellular mechanism between Th2 inflammation in these two anatomical locations. 489 
 490 
Conflicting data have been reported on dependence of IL13-induced goblet cell metaplasia 491 
on NOTCH signalling in ex vivo cultured PBECs25,46. Our data on freshly isolated bronchial 492 
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epithelial cells show that expression of NOTCH2 and Notch target genes is present in goblet 493 
cells from healthy controls only, and absent from ciliated, mucous ciliated and goblet cells 494 
in asthmatic airway wall. This indicates that mucous cell metaplasia in mild asthmatics is 495 
likely to be driven by type-2 cytokines in a NOTCH-independent fashion.  One likely source 496 
of the type-2 cytokines driving this goblet cell metaplasia are the cytokine-expressing 497 
effector Th2 cells that are increased in asthmatic airway wall. To our knowledge, our study 498 
is the first to conclusively show the presence of the recently identified39,40,41 pathogenic 499 
effector Th2 cells in the airway wall in asthma, as evidenced by the combined expression of 500 
IL5, IL13, HPGDS, PPARG, IL17RB, IL1RL1 and IL1RAP. Additional cellular sources for the 501 
type-2 cytokines, including innate lymphoid cells, cannot be ruled out based on our data, as 502 
these cells were present in too low numbers to be analysed in our dataset, and will need to 503 
be purified from the biopsy cell suspensions for further characterization in future studies. 504 
 505 
Finally, our detailed and unbiased analyses of cell-cell communication in healthy and 506 
asthmatic airway wall reveals novel interactions of the airway wall resident cells in health 507 
and disease. Comprehensive analysis of the cell-cell interactions underpinning the changes 508 
of the airway wall cellular landscape in asthma identifies a shift away from interactions 509 
between structural cells in healthy airway wall, towards an intercellular network dominated 510 
by the interactions of Th2 cells with structural and inflammatory cells in asthmatic airway 511 
wall. The richness of growth factor signalling between epithelial cells and mesenchymal cells 512 
observed in healthy airway wall is largely lost in asthma, which seems at odds with a 513 
reactivation of the epithelial-mesenchymal trophic unit in asthma47. Instead, our data 514 
supports a shift in cellular phenotypes in airway wall due to the local production of Th2 515 
cytokines such as IL13 in chronic disease in our patient cohort with childhood-onset asthma. 516 
This global view of the airway wall cellular landscape in health and in asthma opens up new 517 
perspectives on lung biology and molecular mechanisms of asthma. 518 
519 
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Figure 1. A human lung cell census identifies zonation of novel epithelial cell states 684 
across macro-anatomical location. (A) Schematic illustration depicting anatomical 685 
regions analysed in this manuscript. (B) Table with the details of anatomical region, tissue 686 
source, donors and cell numbers present in this figure. (C) tSNE displaying the major 687 
epithelial clusters present in the full extent of the human respiratory tree. (D) Pie charts 688 
depicting the cellular composition by anatomical region. (E) Horizontal slice bar depicting 689 
the anatomical distribution of each cell type identified (F) Heatmap depicting the average 690 
expression levels per cluster of the top differentially expressed markers in each cluster. (G) 691 
Violin plots of selected markers identified by differential expression analysis comparing the 692 
two goblet subsets to each other. (H) Violin plots of selected markers identified by differential 693 
expression analysis of ciliated 1 versus ciliated 2 clusters. (I) Dot plot depicting gene 694 
expression levels and percentage of cells expressing genes associated with specific lung 695 
phenotypes according to the Online Mendelian Inheritance in Man (OMIM) database. Only 696 
genes present in the top 50 (per cluster) of our list of differentially expressed genes are 697 
depicted in (I). All the differential expression analysis were performed using Wilcoxon rank 698 
sum test in Seurat48. 699 
  700 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.




Figure 2. A cellular and molecular map of the stromal and immune components of 702 
across the upper and lower human respiratory airways. (A) Table with details of 703 
anatomical region, tissue source, donors and cell numbers present in this figure. (B)  tSNE 704 
displaying the major immune and mesenchymal clusters present in the full extent of the 705 
human respiratory tree. (C) Pie charts depicting the cellular composition of immune cells by 706 
anatomical region. (D) Pie charts depicting the cellular composition of stromal cells in lower 707 
airway biopsies and parenchyma tissue. (E) Heatmap depicting the average expression 708 
levels per cluster of the top differentially expressed markers in each cluster. (F) Dot plot 709 
depicting gene expression levels and percentage of cells expressing genes associated with 710 
lung phenotypes according to the Online Mendelian Inheritance in Man (OMIM) database. 711 
Only genes present in the top 50 (per cluster) of our list of differentially expressed genes are 712 
depicted in (F). All the differential expression analysis was performed using Wilcoxon rank 713 
sum test in Seurat.  714 
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Figure 3. Distinct programs of epithelial cell differentiation in asthmatic versus 716 
healthy airways. (A) Table with overview and cell numbers for control and asthma 717 
volunteers analysed in this figure. (B) tSNE displaying all epithelial cells analysed coloured 718 
by their specific cluster assignment. (C) Box and whisker plots depicting cell numbers of 719 
control and asthma patients in each cluster. (D) Heatmap displaying the top five differentially 720 
expressed genes per cluster. (E) Pseudotime developmental trajectory analysis from 721 
Monocle2 depicting how each of the basal, secretory and ciliated subsets relate to each 722 
other. (F) Binned pseudotime analysis displaying how each subset is ordered in a one-723 
dimensional continuous space. (G) Heatmap displaying the expression of asthma genes 724 
from GWAS. Only genes present in our list of differentially expressed genes are depicted 725 
for each cell cluster. Significance analysed using Fisher’s exact test corrected for multiple 726 
comparison using the Bonferroni method. Significance calculated using all the clusters 727 
present in figures 3 and 4, which were derived from the same set of samples. *represents 728 
p-value<0.001. n=6 controls and n=6 asthma. The differential expression analysis used for 729 
input in D and E was performed using Wilcoxon rank sum test in Seurat. 730 
  731 
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Figure 4. Remodelling of the stromal and Immune compartments in asthmatic 734 
airways. (A) Table with the number of donors and cells per volunteer group included in this 735 
figure. (B) tSNE depicting the immune and stromal cell types identified in the human airway 736 
combined dataset of healthy and asthmatic patients. (C) Box and whisker plots depicting the 737 
cell numbers of healthy and asthmatic cells in each cluster. (D)  Heatmap displaying gene 738 
expression levels of the top 5 differentially expressed genes per cluster. (E) Violin plots 739 
depicting expression of immunoglobulin genes in B cells. (F) Heatmap displaying asthma 740 
GWAS gene expression per cluster. Only genes present in the top 50 (per cluster) of our list 741 
of differentially expressed genes are shown. (G) Violin plots of selected T cell markers in 742 
asthma patients. Significance calculated using all the clusters present in figures 3 and 4, 743 
which were derived from the same set of samples. *represents p-value<0.001. n=6 controls 744 
and n=6 asthma. 745 
 746 
 747 
  748 
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Figure 5. Pathogenic effector Th2 cells are enriched in asthmatic airways. (A) 750 
Schematic depicting experimental layout of single cell sorting of CD4 T cells from blood and 751 
lung airway biopsies. (B) Table with the number of donors by anatomical location for control 752 
and asthma groups. (C) tSNE displaying clusters of T cells identified by analysing the 753 
combined cells from blood and lung from control and asthma groups. (D) Box and whisker 754 
plots showing the cluster cell distributions from control and asthma patients. (E) Box and 755 
whisker plots depicting the cluster composition per donor according to the tissue source from 756 
which the cells were isolated. (F) Heatmap showing the average expression per cluster of 757 
genes differentially expressed between the two lung specific CD4 T cell populations. Gene 758 
names coloured according to functional categories. (G) tSNE depicting canonical cytokines 759 
from Th1, Th2 and Th17 cells. (H) Box and whisker plots showing the number of Th1, Th2 760 
and Th17 cells defined by canonical cytokines expression and Tregs identified by unbiased 761 
clustering. (I) Heatmap of average cluster gene expression of markers differentially 762 
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expressed between Th1, Th2, Th17 and Treg cells.  Gene names coloured according to 763 
functional categories. Error bars in (D), (E) and (H) represent standard deviation. 764 
Significance analysed using Multiple t-tests corrected for multiple comparison using the 765 
Holm-Sidak method. * represents p-value<0.05. Patient numbers per tissue depicted in (B). 766 
 767 
 768 
  769 
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Figure 6. Asthma is characterized by unique cell-to-cell signalling networks. We 771 
quantified the predicted cell interactions in healthy and asthmatic airways between all the 772 
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epithelial and non-epithelial cell clusters identified in figures 3 and 4, plus the lung airway 773 
enriched populations of CD4 T cells (Th2, Treg, TMC and TRM) (A) Networks depicting cell 774 
types as nodes and interactions as edges. Size of cell type proportional to the total number 775 
of interactions of each cell type and edge thickness proportional to the number of interactions 776 
between the connecting types. (B) Heatmap depicting the number of all possible interactions 777 
between the clusters analysed. Cell types grouped by broad lineage (epithelia, 778 
mesenchymal or immune). (C) Dot plot depicting selected epithelial-epithelial and epithelial-779 
mesenchymal interactions enriched in healthy airways but absent in asthma. (D) Dot plot 780 
depicting selected epithelial-immune and mesenchymal-immune interactions highly 781 
enriched in asthma but absent in healthy airways.  782 
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Patient recruitment and ethical approval 785 
Bronchoscopy biopsy (10x and smartseq2 analysis):  cohort inclusion criteria for all subjects 786 
were: age between 40 – 65 years and history of smoking <10 pack years. For the asthmatics, 787 
inclusion criteria were: age of onset of asthmatic symptoms ≤12 years, documented history 788 
of asthma, use of inhaled corticosteroids with(out) β2-agonists due to respiratory symptoms 789 
and a positive provocation test (i.e. PC20 methacholine ≤8mg/ml with 2-minute protocol). For 790 
the non-asthmatic controls, the following criteria were essential for inclusion: absent history 791 
of asthma, no use of asthma-related medication, a negative provocation test (i.e. PC20 792 
methacholine >8 mg/ml and adenosine 5'-monophosphate >320 mg/ml with 2-minute 793 
protocol), no pulmonary obstruction (i.e. FEV1/FVC ≥70%) and absence of lung function 794 
impairment (i.e. FEV1 ≥80% predicted). 795 
Asthmatics stopped inhaled corticosteroid use 6 weeks prior to all tests. All subjects were 796 
clinically characterised with pulmonary function and provocation tests, blood samples were 797 
drawn, and finally subjects underwent a bronchoscopy under sedation. If a subject 798 
developed upper respiratory symptoms, bronchoscopy was postponed for ≥6 weeks. 799 
Fibreoptic bronchoscopy was performed using a standardised protocol during conscious 800 
sedation [1]. Six macroscopically adequate endobronchial biopsies were collected for this 801 
study, located between the 3rd and 6th generation of the right lower and middle lobe. 802 
Extracted biopsies were processed directly thereafter, with a maximum of one hour delay. 803 
The medical ethics committee of the Groningen University Medical Center Groningen 804 
approved the study, and all subjects gave their written informed consent. Detailed patient 805 





Lung resection (Dropseq analysis): Fresh resected human lung tissue (parenchymal lung 811 
and distal airway specimens) was obtained via the CPC BioArchive at the Comprehensive 812 
Pneumology Center Munich (CPC-M, Munich, Germany). In total, we analysed parenchymal 813 
tissue of uninvolved areas of tumour resection material from four patients. All participants 814 
gave written informed consent and the study was approved by the local ethics committee of 815 
the Ludwig-Maximilians University of Munich, Germany.  816 
For transport from the surgeon to the laboratory, lung tissue samples were stored in ice-cold 817 
DMEM-F12 media and packed in thermo stable boxes. Tissue was processed with a 818 
maximum delay of 2 hours after surgery. Upon delivery to the lab, tissue samples were 819 
assessed visually for qualification for the study.  820 
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Donor information: 821 
 822 
ID Sample Gender Age Smoker Segment COPD 
muc3843 ASK428 m 62 yes, 
>100py 
lower lobe, left COPD Gold II 
muc4658 ASK440 m 58 yes, 45py upper lobe, left no 
muc5103 ASK452 m 58 no main bronchus no 
muc5104 ASK454 m 69 yes, >60py upper lobe, left no 
Lung transplant tissue (10x analysis): Human lung tissue was obtained from deceased organ 823 
donors from whom organs were being retrieved for transplantation. Informed consent for the 824 
use of tissue was obtained from the donors’ families (REC reference: 15/EE/0152 NRES 825 
Committee East of England - Cambridge South).  826 
Fresh tissue from the peripheral parenchyma of the left lower lobe or lower right lobe of the 827 
lung was excised within 60 minutes of circulatory arrest and preserved in University of 828 
Wisconsin (UW) organ preservation solution (Belzer UW® Cold Storage Solution, Bridge to 829 
Life, USA) until processing.  830 
 831 
Donor information: 832 
 833 
Donor 284C  834 
Gender: Male  835 
Age band: 55-60  836 
BMI: 25.83  837 
Cause of Death: hypoxic brain damage 838 
Smoking history: smoked 20/day for 25 years  839 
Stopped: 08/2000 840 
Respiratory related information: Chest X-ray normal on admission. No pleural effusion or 841 
pneumothorax. Not diagnosed with asthma, but inhalers for possible seasonal wheeze. 842 
Family report only using inhaler approximately 5 times a year. No recent peak flow on record 843 
last one in 2008 when it was 460, predicted is 611. 844 
Time from death to cell lysis: 12h 845 
  846 
Donor 290B 847 
Gender: Female  848 
Age band: 60-65  849 
BMI: 27.77  850 
Cause of Death: hypoxic brain damage 851 
Smoking history: smoked 15/day for 7 years  852 
Stopped: no details 853 
Respiratory related information: Respiratory tests all normal on admission; maintaining own 854 
airway. GP notes report Acute bronchitis in 1994. 855 
Time from death to cell lysis: 2h 27min 856 
  857 
Donor: 292B  858 
Gender: Male  859 
Age band: 55-60  860 
BMI: 27.44  861 
Cause of Death: Intracranial haemorrhage 862 
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Smoking history: smoked 20/day for 46 years  863 
Stopped: no details 864 
Respiratory related information: Chest X-ray normal on admission, lungs appear clear. 865 
Bronchoscopy results show global inflamed mucosa. No other history of respiratory issues. 866 
Time from death to cell lysis: 18h 50min 867 
  868 
Donor: 296C  869 
Gender: Female  870 
Age band: 30-35  871 
BMI: 20.9  872 
Cause of Death: Intracranial haemorrhage 873 
Smoking history: smoked 20/day for 19 years 874 
Stopped: no details 875 
Respiratory related information: Chest X-ray shows collapsed left lobe on admission due to 876 
consolidation. Right lobe looks normal. No history or record of respiratory issues. 877 
Time from death to cell lysis: 15h 30min 878 
  879 
Donor: 298C  880 
Gender: Male  881 
Age band: 50-55  882 
BMI:  24 883 
Cause of Death: Intracranial haemorrhage  884 
Smoking history: not available 885 
Stopped: no details 886 
Respiratory related information: no details 887 
Time from death to cell lysis: 15h 30min 888 
 889 
Donor: 302C  890 
Gender: Male  891 
Age band: 40-45  892 
BMI: 34.33  893 
Cause of Death: Known or suspected suicide 894 
Smoking history: smoked 20/day for 25 years  895 
Stopped: no details 896 
Respiratory related information: Chest X-ray shows reduced volume in right lung due to 897 
collapsed right lower lobe on admission. No history or record of respiratory issues. 898 
Time from death to cell lysis: 13h 30min 899 
 900 
Archived formalin-fixed paraffin-embedded (FFPE) lung blocks: Left-over frozen peripheral 901 
lung tissues from 6 current smokers and 4 non-smokers who underwent lung resection 902 
surgery. These subjects did not have a history of lung disease, apart from lung cancer for 903 
which the patients underwent surgery. Lung tissue samples were taken as distant from the 904 
tumor as possible. Thus, any possible effect of the tumor on the lung tissue was minimized. 905 
All samples were obtained according to national and local ethical guidelines and the 906 
research code of the University Medical Center Groningen. 907 
 908 
Bio sample code Age Gender Smoking status Diagnosis 
GRNG-LNG_MRK085 45 female current smoker LCC 
GRNG-LNG_MRK125 54 female current smoker AC 
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GRNG-LNG_MRK177 52 female current smoker AC 
GRNG-LNG_MRK188 70 male current smoker SCC 
GRNG-LNG_MRK218 61 male current smoker Metastasis 
GRNG-LNG_MRK245 65 female current smoker LCC 
GRNG-LNG_0758 81 female non-smoker AC 
GRNG-LNG_0764 49 male non-smoker carcinoid 
GRNG-LNG_0802 50 male non-smoker metastasis 
GRNG-LNG_0830 45 male non-smoker IMT 
LCC = large cell carcinoma, AC = adenocarcinoma, SCC = squamous cell carcinoma and IMT = inflammatory myofibroblast 
tumor 
 909 
Blood processing 910 
Lithium Heparin- anticoagulated whole blood (500µl) was lysed using an ammonium 911 
chloride-potassium solution (155mM ammonium chloride (NH4Cl), 10mM potassium 912 
bicarbonate (KHCO3), 0,1mM EDTA). Cells were centrifuged for 5 min at 4°C, 550g after 913 
which the cell pellet was washed twice with PBS containing 1% BSA, followed by staining 914 
for cell surface markers. 915 
 916 
Lung tissue processing 917 
Bronchoscopy biopsy: A single cell solution was obtained by chopping the biopsies finely 918 
using a single edge razor blade. The chopped tissue was then put in a mixture of 1mg/ml 919 
collagenase D and 0.1mg/ml DNase I (Roche) in HBSS (Lonza). This was then placed at 920 
37°C for 1hr with gentle agitation. The single cell suspension was forced through a 70µm 921 
nylon cell strainer (Falcon). The suspension was centrifuged at 550g, 4°C for 5 min and 922 
washed once with a PBS containing 1% BSA (Sigma Aldrich). The single cell suspensions 923 
used for 10X Genomics scRNAseq analysis were cleared of red blood cells by using a Red 924 
blood cell lysis buffer (eBioscience) followed by staining for cell surface markers.  925 
 926 
Lung tissue resection: For each sample, 1-1.5 g of tissue was homogenized by mincing with 927 
scissors into smaller pieces (~0.5 mm2/piece). Prior to tissue digestion, lung homogenates 928 
were cleared from excessive blood by addition of 35 ml of ice-cold PBS, followed by gentle 929 
shaking and tissue collection using a 40μm strainer. The bloody filtrate was discarded. The 930 
tissue was transferred into 8 ml of enzyme mix consisting of dispase (50 caseinolytic U/ml), 931 
collagenase (2 mg/ml), elastase (1 mg/ml), and DNase (30 µg/ml) for mild enzymatic 932 
digestion for 1 hour at 37°C while shaking. Enzyme activity was inhibited by adding 5 ml of 933 
PBS supplemented with 10% FCS. Dissociated cells in suspension were passed through a 934 
70μm strainer and centrifuged at 300g for 5 minutes at 4°C. The cell pellet was resuspended 935 
in 3 ml of red blood cell lysis buffer and incubated at room temperature for 2 minutes to lyse 936 
remaining red blood cells. After incubation, 10 ml of PBS supplemented with 10% FCS was 937 
added to the suspension and the mix was centrifuged at 300g for 5 minutes at 4°C. The cells 938 
were taken up in 1 ml of PBS supplemented with 10% FCS, counted using a Neubauer 939 
chamber and critically assessed for single cell separation. Dead cells were counted to 940 
calculate the overall cell viability, which needed to be above 85% to continue with Drop-Seq. 941 
250,000 cells were aliquoted in 2.5 ml of PBS supplemented with 0.04% of bovine serum 942 
albumin and loaded for Drop-Seq at a final concentration of 100 cells/μl. 943 
 944 
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Rejected lung transplant: for each sample, 1-2g of tissue was divided in 5 smaller pieces 945 
then transferred to 5ml eppendorfs containing 1.5ml 0.5mg/ml collagenase D and 0.1mg/ml 946 
DNase I (Sigma) in RPMI. Samples were then finely minced using scissors. Minced tissue 947 
was then transferred to a petry dish and extra digestion medium added to completely cover 948 
the tissue. Samples were incubated 30min at 37°C. Cells were then passed up and down 949 
through a 16-gauge needle 10 times. Samples were incubated for an additional 15min at 950 
37°C. Cells were filtered a 70um filter, then spun down for 6min 1400RPM. 1 ml of red blood 951 
cell lysis (eBioscience) was added to the pellet during 5min. Cells were resuspended in 952 
RPMI + 10%FCS and counted. Dead cells were removed using the Dead Cell Removal Kit 953 
(Miltenyi Biotec). In brief, cells were incubated with anti-Annexin V beads for 15min. The cell 954 
suspension was then passed through a magnetic column and dead Annexin V+ cells 955 
remained in the column, while live cells were collected. Viability was then estimated via 956 
trypan blue. More than 99% of cells were viable. 957 
 958 
Flow cytometry 959 
Blood leukocytes were stained with CD4 APC-Cy7, CD3 PerCP Cy5.5 and CD8 APC 960 
(eBioscience) for 30min at 4°C and washed twice with PBS containing 1% BSA. Propidium 961 
iodide (PI) was added 5min before sorting.  962 
Airway wall biopsy single cell suspensions were stained for 30min at 4°C with CD3 PerCP 963 
Cy5.5, CD45 BB515, CD4 APC Cy7 (BD) and CD8 PE and washed twice with PBS 964 
containing 1% BSA. Propidium iodide (IQ products) was added 5min before sorting. 965 
 966 
Cell Sorting 967 
Lymphocytes were selected in the FCS/SSC plot. These were then selected on single, live 968 
cells for blood or single, live, CD45+ for lung. The sorted cells were positive for CD3 & CD4 969 
as shown in figure 5A. All cells were sorted in a MoFlo Astrios (Beckman Coulter) using 970 
Summit Software (Beckman Coulter). 971 
 972 
Immunohistochemical staining:  973 
Human lung tissue containing large airways were collected from archival formalin-fixed 974 
paraffin-embedded (FFPE) blocks (n=10, 6 smokers and 4 non-smokers). Serial sections 975 
(∼4 µm) were cut for immunohistochemistry (IHC) and immunofluorescent (IF) staining. 976 
Serial sections from FFPE lung tissue were stained for using standard protocols, with 977 
antibodies specified in the figures. Briefly, serial sections were deparaffinized in xylene, 978 
rehydrated and immersed in 10 mM sodium citrate buffer (pH 6.0). Antigen retrieval was 979 
performed by boiling the sections in a pressure cooker at 120°C for 20 min. 980 
IHC and IF staining was performed as described previously49,50. For the IHC staining cells 981 
were stained with a primary antibody (see below for Ab details) and visualized with 982 
diaminobenzidine (DAB, Sigma) solution. For the IF staining, cells were stained with primary 983 
antibody. Secondary antibodies conjugated to fluorophores (donkey anti rabbit-488, donkey 984 
anti mouse-555) were used at a dilution of 1:100. DAPI, dissolved in Dako Fluorescence 985 
Mounting Medium (Dako S3023) at a dilution of 1:1000, was used as a nuclear stain. 986 
 987 
 988 
Antibody list: 989 
 990 
Antibody Fluorochrome Clone Supplier Catalog  
CD45 BB515 HI30 BD biosciences 564585 
CD3 PerCP Cy5.5 SP34-2 BD biosciences 552852 
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CD4 APC Cy7 RPA-T4 BD biosciences 557871 
FOXI1 unlabelled 2B8 LSBio LS-C336930 
CFTR unlabelled polyclonal Human atlas  HPA021939 
Synaptophysin unlabelled SP11 Ventana Medical 
Systems  
790-4407 






α-Tubulin unlabelled DM1A Sigma/MERCK  T9026-100UL 
Donkey anti 
rabbit-488 





AF 555 Polyclonal Thermo Fisher 
Scientific 
# A-31570 




Chromium 10x Genomics library and sequencing 992 
Airway biopsy: Single cell suspensions were manually counted using a haemocytometer and 993 
concentration adjusted to a minimum of 300 cells/ul. Cells were loaded according to 994 
standard protocol of the Chromium single cell 3’ kit in order to capture between 2000-5000 995 
cells/chip position. All the following steps were performed according to the standard protocol. 996 
Initially, we used one lane of an Illumina Hiseq 4000 per 10x Genomics chip position. 997 
Additional sequencing was performed in order to obtain coverage of at least mean coverage 998 
of 100.000 reads/cell.  999 
Lung transplant: Single cell suspensions were manually counted using a haemocytometer 1000 
and concentration adjusted to 1000 cells/ul. Cells were loaded according to standard 1001 
protocol of the Chromium single cell 3’ kit in order to capture between 2000-5000 cells/chip 1002 
position. All the following steps were performed according to the standard manufacturer 1003 
protocol. Initially, we used one lane of an Illumina Hiseq 4000 per 10x Genomics chip 1004 
position. Additional sequencing was performed in order to obtain coverage of at least mean 1005 
coverage of 100.000 reads/cell.  1006 
 1007 
SmartSeq 2 library preparation and sequencing 1008 
Library preparation was performed with minor modifications from the published SmartSeq2 1009 
protocol51. In short, single cells were flow sorted onto individual wells of 96 or 384 wells 1010 
containing 4ul (96 wells) or 1ul (384 wells) of lysis buffer (0.3% triton plus DNTPs and 1011 
OligoDT). After sorting, plates were frozen and stored at -80 until further processing. RT, 1012 
PCR (25 cycles) and nextera library preparation performed as described in 51. 1013 
 1014 
Dropseq library preparation and sequencing 1015 
Drop-seq experiments were performed largely as described previously7 with few adaptations 1016 
during the single cell library preparation. Briefly, using a microfluidic polydimethylsiloxane 1017 
(PDMS) device (Nanoshift), single cells (100/µl) from the lung cell suspension were co-1018 
encapsulated in droplets with barcoded beads (120/µl, purchased from ChemGenes 1019 
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Corporation, Wilmington, MA) at rates of 4000 µl/hr. Droplet emulsions were collected for 15 1020 
min/each prior to droplet breakage by perfluorooctanol (Sigma-Aldrich). After breakage, 1021 
beads were harvested and the hybridized mRNA transcripts reverse transcribed (Maxima 1022 
RT, Thermo Fisher). Unused primers were removed by the addition of exonuclease I (New 1023 
England Biolabs), following which beads were washed, counted, and aliquoted for pre-1024 
amplification (2000 beads/reaction, equals ~100 cells/reaction) with 12 PCR cycles (primers, 1025 
chemistry, and cycle conditions identical to those previously described. PCR products were 1026 
pooled and purified twice by 0.6x clean-up beads (CleanNA). Prior to tagmentation, cDNA 1027 
samples were loaded on a DNA High Sensitivity Chip on the 2100 Bioanalyzer (Agilent) to 1028 
ensure transcript integrity, purity, and amount. For each sample, 1 ng of pre-amplified cDNA 1029 
from an estimated 1000 cells was tagmented by Nextera XT (Illumina) with a custom P5 1030 
primer (Integrated DNA Technologies). Single cell libraries were sequenced in a 100 bp 1031 
paired-end run on the Illumina HiSeq4000 using 0.2 nM denatured sample and 5% PhiX 1032 
spike-in. For priming of read 1, 0.5 µM Read1CustSeqB (primer sequence: 1033 
GCCTGTCCGCGGAAGCAGTGGTATCAACGCAGAGTAC) was used. 1034 
 1035 
Bulk Transcriptome 1036 
Biopsies were fresh frozen in liquid nitrogen and stored in -80. RNA was extracted after a 1037 
few weeks using a combination of Trizol & the RNeasy MinElute Clean Up kit from Qiagen. 1038 
RNA was prepared from sequencing using the TruSeq RNA Library Prep Kit v2. Samples 1039 
were then sequenced inn a Hiseq 4000. 1040 
 1041 
 1042 
Single-cell RNA sequencing data alignment 1043 
For SmartSeq2 raw sequencing data, paired-end reads were mapped to the Human genome 1044 
(GRCh38) using GSNAP with default parameters52. Then, uniquely mapped reads were 1045 
counted using htseq-count (http://www-huber.embl.de/users/anders/HTSeq/). Low-quality 1046 
cells were filtered out using the outlier detection algorithm in R Scater package based on a 1047 
cut-off of 2*MAD (median-absolute-deviation). 1048 
10X Genomics raw sequencing data was processed using CellRanger software version 1049 
2.0.2 and the 10X human genome GRCh38 1.2.0 release as the reference. 1050 
The Dropseq core computational pipeline was used for processing next generation 1051 
sequencing reads of the Dropseq scRNA-seq data, as previously described7. Briefly, STAR 1052 
(version 2.5.2a) was used for mapping53 . Reads were aligned to the human reference 1053 
genome hg19 (provided by Dropseq group, GSE63269). 1054 
 1055 
Bulk transcriptome computational analysis 1056 
The bulk samples were aligned using STAR 2.5.1b, using the STAR index from the GRCh38 1057 
reference that was used when mapping 10X data, and quantified using HTSeq. The data 1058 
was then processed using the Seurat-inspired workflow within Scanpy, adding a number of 1059 
"pseudo-bulks" obtained by taking 10X data from donors matching the bulk samples and 1060 
summing expression across all cells. 1061 
 1062 
Data QC 1063 
General strategy for 10x datasets: Optimal tissue dissociation conditions are cell-type 1064 
dependent, resulting in a certain degree of cell lysis when working with a mixed tissue 1065 
sample. This results in substantial background levels of ambient RNA in the single-cell 1066 
suspension that vary with cell type composition, so we applied SoupX for background 1067 
correction (see below). We analysed each donor sample separately and excluded cells with 1068 
a number of genes higher than the median+2SDs for that donor. We further excluded cell 1069 
with high number of UMIs and high percentage of mitochondrial reads (see below).  1070 
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In parallel, we used scrublet (see below) to infer the number of the doublets in the dataset 1071 
before applying the filters previously described and excluded any remaining cells predicted 1072 
to be doublets that were still present in the dataset. We normalised and scaled our data (see 1073 
below), performed clustering (see below) and identified and subset the data into epithelial 1074 
and non-epithelial cell groups (as shown in supplementary figures 1 and 6). After separation 1075 
between epithelial and non-epithelial, we clustered the cells and performed curated doublet 1076 
removal (see below) based on known lineage restricted markers. 1077 
 1078 
General strategy for Dropseq data: We normalised and scaled the data, then performed 1079 
filtering based on the number of genes and percentage of mitochondrial reads.  1080 
 1081 
General strategy smartseq2 data: We normalised and scaled the data, then performed 1082 
filtering based on the number of genes and percentage of mitochondrial reads. In order to 1083 
avoid potential batch effects from the lung digestion protocol, we corrected the gene 1084 
expression of the CD4 SmartSeq2 dataset using a small subset of genes the expression of 1085 
which has been recently shown to be highly responsive to enzymatic digestion54 : FOS, 1086 
ZFP36, JUN, FOSB, HSPA1A, JUNB, EGR1, UBC. 1087 
 1088 
Ambient RNA correction (SoupX) 1089 
Different batches can be affected by different levels of ambient RNA. To take this into 1090 
account, we used the recently developed SoupX method55. Briefly, ambient RNA expression 1091 
is estimated from the empty droplet pool (10 UMI or less). Expression of these genes in each 1092 
cell is then calculated and compared to their proportion in the ambient RNA profile. 1093 
Transcripts with a bimodal profile (i.e. that characterize specific groups of cells but are also 1094 
highly abundant in empty droplets) are then grouped based on their function. The 1095 
contamination fraction derived from the expression of these genes is then used to calculate 1096 
the fraction of each droplet’s expression corresponding to the actual cell. Finally, this fraction 1097 
and the ambient profiles are subtracted from the real expression values. 1098 
 1099 
UMI and number of genes filtering 1100 
10x data (After SoupX correction):  1101 
nUMI: minimum 1000/ maximum 60000. 1102 
percent.mito, minimum 0 /  maximum= 3% 1103 
SmartSeq2 data: 1104 
 nGene : minimum 1000 / maximum 4000.  1105 
percent.mito, minimum 0 /  maximum= 15% 1106 
Dropseq data:  1107 
 nGene: minimum 200/ maximum 4000. 1108 
percent.mito, minimum 0 /  maximum= 20% 1109 
 1110 
Scrublet 1111 
We used Scrublet (Wolock et al, BioRxiv, https://doi.org/10.1101/357368) for unbiased 1112 
computational doublet inference.  Doublets were identified in each 10X sample individually 1113 
using scrublet, setting the expected doublet rate to 0.03 and keeping all other parameters 1114 
at their default values. Cells  were excluded when they had a score higher than 0.1 for upper 1115 
and lower airway samples or higher than 0.05 for parenchyma samples. 1116 
 1117 
Normalisation and scaling 1118 
Downstream analyses including, normalisation, scaling, clustering of cells and identifying 1119 
cluster marker genes were performed using the R software package Seurat48 version 2.1 1120 
(https://github.com/satijalab/seurat). 1121 
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Samples were log normalised and scaled for the number of genes, number of UMIs and 1122 
percentage of mitochondrial reads. The epithelial biopsy dataset comparing healthy and 1123 
asthma was also scaled for XIST expression, as we observed some gender specific clusters 1124 
of cells that shared lineage markers with the other observed clusters. 1125 
 1126 
Curated doublet removal 1127 
We combined literature knowledge about cell lineages with over clustering to identify 1128 
clusters enriched in potential doublets. The strategy for each dataset is shown below: 1129 
 1130 
Lung atlas epithelial dataset (Figure 1 and associated extended data figures): We removed  1131 
cells with expression level higher than 0.5 for any of the following markers: PTPRC 1132 
(immune),FCER1G (immune), PDGFRA (fibroblast) or PECAM1 (endothelial).  1133 
 1134 
Lung atlas non-epithelial dataset (Figure 2 and associated extended data figures): We 1135 
removed  cells with expression level higher than 0.5 for any of the following markers: EPCAM 1136 
(epithelial),KRT5 (basal), “FOXJ1”(ciliated) or MUC5AC (secretory). We then performed first 1137 
clustering round (7 PCs, resolution 2) and excluded  clusters that expressed combinations 1138 
of the following lineage specific markers: MARCO(macrophage), CCL21 (lymphatic 1139 
endothelial), TPSB2 (mast cell) or CD3D(T cell).  We performed a second clustering round 1140 
and exclude a cluster formed by cells from one donor that had low expression TPSB2, while 1141 
lacking markers for all other immune lineages.  1142 
 1143 
Asthma biopsy epithelial cells (Figure 3 and associated extended data figures): due to the 1144 
smaller number of cells, we only performed cluster-based doublet exclusion, without cell 1145 
filtering. We performed one round of clustering and removed one clusters with high 1146 
expression of PECAM1 (endothelial marker). 1147 
 1148 
Asthma biopsy non-epithelial cells (Figure 4 and associated extended data figures): we 1149 
performed three rounds of clustering where we excluded clusters with high levels of EPCAM 1150 
or KRT5 expressed in much higher levels than immune lineage markers. 1151 
 1152 
Dimensionality reduction 1153 
We performed PCA dimensionality reduction with the highly variable genes as input. We 1154 
then used the PCs to calculate t-Distributed Stochastic Neighbour Embedding (t-SNE) for 1155 
each dataset, using a perplexity value of 50. 1156 
 1157 
Data clustering 1158 
We used the function “FindClusters” from Seurat. In brief, this method uses a shared nearest 1159 
neighbour (SNN) modularity optimization-based clustering algorithm to identify clusters of 1160 
cells based on their PCs. Before constructing the SNN graph, this function calculates k-1161 
nearest neighbours (we used k=30) and then it constructs the SNN graph. The number of 1162 
PCs used for each clustering round was dataset dependent and they were estimated by the 1163 
elbow of a PCA scree plot, in combination to manual exploration of the top genes from each 1164 
PC. 1165 
 1166 
DE analysis 1167 
We used a Wilcoxon rank sum test to identify differentially expressed genes in all the 1168 
comparisons here discussed. 1169 
 1170 
MatchScore 1171 
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We used MatchSCore8 to quantify the overlap of cell type marker signatures between 1172 
experiments, which is based on the Jaccard index. Only marker genes with adjusted p-value 1173 
< 0.1 and average log fold change > 1 were considered. 1174 
 1175 
CellPhoneDB 1176 
We developed a manually curated repository of ligands, receptors and their interactions 1177 
called CellPhoneDB (www.cellphonedb.org; Vento-Tormo, Efremova et al., Nature, 2018), 1178 
integrated with a statistical framework for predicting cell-cell communication networks from 1179 
single cell transcriptome data. Briefly, the method infers potential receptor-ligand 1180 
interactions based on expression of a receptor by one cell type and a ligand by another cell 1181 
type. Only receptors and ligands expressed in more than 30% of the cells in the specific 1182 
cluster were considered. In order to identify the most relevant interactions between cell 1183 
types, the method prioritizes ligand-receptor interactions that have cell type-specific 1184 
expression. To this end, pairwise cluster-cluster interaction analysis are performed by 1185 
randomly permuting the cluster labels of each cell 1000 times. For each permutation, the 1186 
total mean of the average receptor expression level of a cluster and the average ligand 1187 
expression level of the interacting cluster is calculated, and a null distribution is derived for 1188 
each receptor-ligand pair in each cluster-cluster interaction. An empirical p-value is 1189 
calculated from the proportion of the means which are "as or more extreme" than the actual 1190 
mean. For the multi-subunit heteromeric complexes, the member of the complex with the 1191 
minimum average expression is used for calculating the mean. 1192 
Network visualization was done using Cytoscape (version 3.5.1). All the interaction pairs 1193 
with collagens were removed from the analysis. The networks layout was set to force-1194 
directed layout. 1195 
 1196 
Trajectory analysis 1197 
Trajectory analysis was performed using Monocle version 2.2.0 23. We ordered the cells onto 1198 
a pseudotime trajectory based on the union of highly variable genes obtained from all cells, 1199 
as well as those from only healthy or asthmatic donors. 1200 
  1201 
Supervised analyses using GWAS genes 1202 
Asthma-associated GWAS gene list was collected using  the GWAS Catalog of EMBL-EBI 1203 
searching for the term asthma (https://www.ebi.ac.uk/gwas/). The list was downloaded on 1204 
8th of February 2018. We took the genes that are in the top 50 hits of our single-cell DE 1205 
marker list (either epithelial or non-epithelial) and asthma-associated GWAS list (the 1206 
“matched” gene list). We then hierarchically clustered the expression matrix of the matched 1207 
gene list along its rows (genes) and columns (single cells) and represented this as a 1208 
heatmap. 1209 
 1210 
Neuroendocrine cell identification 1211 
Neuroendocrine cells were identified by the expression of CHGA. Any cell expressing any 1212 
amount of CHGA was classified as a neuroendocrine cell. 1213 
 1214 
OMIM search for lung diseases  1215 
We searched the clinical synopses with known molecular basis in the Online Mendelian 1216 
Inheritance in Man (OMIM) database® for the following terms: 'pulm*’ or ‘bronchi*’ or ‘alveol*’ 1217 
or ‘surfactant’ and retrieved 337 entries. These terms were chosen to minimise the return of 1218 
genetic conditions causing respiratory insufficiency as a consequence of neuromuscular 1219 
dysfunction, skeletal dysplasia (small rib cage) or lung segmentation defects arising in early 1220 
embryogenesis. These 337 entries were then manually curated to identify those conditions 1221 
with features affecting the bronchial tree, alveoli, lung parenchyma and pulmonary 1222 
vasculature. On manual review, entries containing terms such as ‘alveolar ridge’ of the jaw 1223 
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and ‘pulmonary valve stenosis’ and ‘pulmonary embolism’, but no terms related to primary 1224 
pulmonary disorders, were excluded from further consideration. Syndromes caused by 1225 
chromosomal disorder or contiguous gene deletion were excluded. 1226 
 1227 
Statistical methods 1228 
For 10x samples comparing healthy versus asthma, we used Fisher’s exact test corrected 1229 
for multiple testing with Bonferroni method. Normalised CD4 cluster proportions were 1230 
analysed via paired t-tests corrected for multiple testing with Holm-Sidak method. 1231 
 1232 
  1233 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.




.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/527408doi: bioRxiv preprint first posted online Jan. 23, 2019; 
